Venue: JW Marriott Hotel

Location: Washington DC, United States

Event Date/Time: May 16, 2001 End Date/Time: May 18, 2001
Paper Submission Date: Apr 06, 2001
Report as Spam


Ultrasensitive, ultraspecific, and ultrahigh-throughput detection have all seen advances in recent years. New technologies and improvements in existing instrumentation push the envelope of detection limits. New probes and labels, homogeneous assay designs, and direct detection of compounds or specific binding events are having an impact on applied and basic research, diagnostics, drug discovery and development, and screening for contaminants and pathogens in the field. Real-time or reduced-time results can pay off in faster time for clinical trials or by avoiding unnecessary therapy. Miniaturization, including microarrays and protein chips, promises a major impact. But cost-effectiveness, reproducibility, robustness, ease of use, and technologies and instrumentation already familiar to existing staff also factor in analyzing tradeoffs. Relevant applications include the detection, quantification, and localization of genes and proteins, pathogens, and environmental and a variety of other targets.